L, Z., Y, L., T, C., J, C., H, Y., X, W., . . . C, P. (2021). Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma. Dove Medical Press.
Chicago Style (17th ed.) CitationL, Zhang, Luo Y, Cheng T, Chen J, Yang H, Wen X, Jiang Z, Li H, and Pan C. Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma. Dove Medical Press, 2021.
MLA (8th ed.) CitationL, Zhang, et al. Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma. Dove Medical Press, 2021.
Warning: These citations may not always be 100% accurate.